146 related articles for article (PubMed ID: 10775753)
1. Antibacterial properties of KwaZulu natal snake venoms.
Blaylock RS
Toxicon; 2000 Nov; 38(11):1529-34. PubMed ID: 10775753
[TBL] [Abstract][Full Text] [Related]
2. Expanding the neutralization scope of the EchiTAb-plus-ICP antivenom to include venoms of elapids from Southern Africa.
Sánchez A; Segura Á; Vargas M; Herrera M; Villalta M; Estrada R; Wu F; Litschka-Koen T; Perry MA; Alape-Girón A; León G
Toxicon; 2017 Jan; 125():59-64. PubMed ID: 27890775
[TBL] [Abstract][Full Text] [Related]
3. The diagnosis and management of snakebite in dogs--a southern African perspective.
Leisewitz AL; Blaylock RS; Kettner F; Goodhead A; Goddard A; Schoeman JP
J S Afr Vet Assoc; 2004 Mar; 75(1):7-13. PubMed ID: 15214688
[TBL] [Abstract][Full Text] [Related]
4. Retrospective study of snake envenomation in 155 dogs from the Onderstepoort area of South Africa.
Lobetti RG; Joubert K
J S Afr Vet Assoc; 2004 Dec; 75(4):169-72. PubMed ID: 15830600
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial Activity of Venom from the Puff Adder (
Okumu MO; Eyaan KL; Bett LK; Gitahi N
Int J Microbiol; 2023; 2023():7924853. PubMed ID: 36908982
[No Abstract] [Full Text] [Related]
6. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and mortality following envenomation by the common night adder (Causus rhombeatus) in three dogs.
de Cramer KG; van Bart GA; Huberts F
J S Afr Vet Assoc; 2012 Oct; 83(1):205. PubMed ID: 23327143
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of snakebite in Eshowe, KwaZulu-Natal, South Africa.
Blaylock R
Toxicon; 2004 Feb; 43(2):159-66. PubMed ID: 15019475
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of snake, scorpion and bee venoms: a comparison with purified venom phospholipase A2 enzymes.
Perumal Samy R; Gopalakrishnakone P; Thwin MM; Chow TK; Bow H; Yap EH; Thong TW
J Appl Microbiol; 2007 Mar; 102(3):650-9. PubMed ID: 17309613
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of bacterial biofilms by the snake venom proteome.
Khan NA; Amorim FG; Dunbar JP; Leonard D; Redureau D; Quinton L; Dugon MM; Boyd A
Biotechnol Rep (Amst); 2023 Sep; 39():e00810. PubMed ID: 37559690
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the cytolytic activity of snake venoms from African spitting cobras (Naja spp., Elapidae) and its neutralization by a polyspecific antivenom.
Méndez I; Gutiérrez JM; Angulo Y; Calvete JJ; Lomonte B
Toxicon; 2011 Nov; 58(6-7):558-64. PubMed ID: 21924279
[TBL] [Abstract][Full Text] [Related]
12. Snake venomics of Bitis species reveals large intragenus venom toxin composition variation: application to taxonomy of congeneric taxa.
Calvete JJ; Escolano J; Sanz L
J Proteome Res; 2007 Jul; 6(7):2732-45. PubMed ID: 17559253
[TBL] [Abstract][Full Text] [Related]
13. Validation of a cell-based assay to differentiate between the cytotoxic effects of elapid snake venoms.
Kalam Y; Isbister GK; Mirtschin P; Hodgson WC; Konstantakopoulos N
J Pharmacol Toxicol Methods; 2011; 63(2):137-42. PubMed ID: 20849965
[TBL] [Abstract][Full Text] [Related]
14. [Biochemical variations of West African snake venoms].
Boche J; Chippaux JP; Courtois B
Bull Soc Pathol Exot Filiales; 1981; 74(3):356-66. PubMed ID: 7285271
[TBL] [Abstract][Full Text] [Related]
15. Snake venoms promote stress-induced senescence in human fibroblasts.
Lewinska A; Bocian A; Petrilla V; Adamczyk-Grochala J; Szymura K; Hendzel W; Kaleniuk E; Hus KK; Petrillova M; Wnuk M
J Cell Physiol; 2019 May; 234(5):6147-6160. PubMed ID: 30317566
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the Antimicrobial Activity of Few Saudi Arabian Snake Venoms.
Al-Asmari AK; Abbasmanthiri R; Abdo Osman NM; Siddiqui Y; Al-Bannah FA; Al-Rawi AM; Al-Asmari SA
Open Microbiol J; 2015; 9():18-25. PubMed ID: 26668657
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Antifungal Activity of
Kuna E; Bocian A; Hus KK; Petrilla V; Petrillova M; Legath J; Lewinska A; Wnuk M
Toxins (Basel); 2020 Aug; 12(8):. PubMed ID: 32759763
[TBL] [Abstract][Full Text] [Related]
18. Unexpected lack of specialisation in the flow properties of spitting cobra venom.
Avella I; Barajas-Ledesma E; Casewell NR; Harrison RA; Rowley PD; Crittenden E; Wüster W; Castiglia R; Holland C; van der Meijden A
J Exp Biol; 2021 Apr; 224(Pt 7):. PubMed ID: 33827968
[TBL] [Abstract][Full Text] [Related]
19. Unexpected lack of specialisation in the flow properties of spitting cobra venom.
Avella I; Barajas-Ledesma E; Casewell NR; Harrison RA; Rowley PD; Crittenden E; Wüster W; Castiglia R; Holland C; van der Meijden A
J Exp Biol; 2021 Apr; 224(7):. PubMed ID: 34424974
[TBL] [Abstract][Full Text] [Related]
20. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
Seddik SS; Wanas S; Helmy MH; Hashem M
J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
